middle.news

INOVIQ’s CAR-Exosomes Achieve Up to 90% Tumour Kill in Ovarian Cancer Cells

8:46am on Thursday 25th of June, 2026 AEST Biotechnology
Read Story

INOVIQ’s CAR-Exosomes Achieve Up to 90% Tumour Kill in Ovarian Cancer Cells

8:46am on Thursday 25th of June, 2026 AEST
Key Points
  • CAR-exosomes killed over 90% of ovarian cancer cells in vitro
  • Effective against aggressive and drug-resistant ovarian cancer lines
  • Platform shows promise across multiple solid tumours including TNBC and NSCLC
  • Manufacturing readiness progressing with GMP cell sourcing and CDMO selection
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Inoviq (ASX:IIQ)
OPEN ARTICLE